Join our community of smart investors

Market Outlook: Are UK equities about to shine? Vaccine approval, G4S, Avon Rubber & more

Despite positive news on the first Covid 19 vaccine approval worldwide in the UK this morning, traders in London are taking some profits off the table
December 2, 2020
  • FTSE100 is flat but mid and small caps are in the red
  • Short term concerns over political uncertainty, including the Brexit situation, but longer term many are talking up the value of the UK market

The UK is a ‘buy’ is fast becoming the consensus view. As per Goldman Sachs yesterday, chiming views expressed here in recent weeks, UK equities are due to catch up. Analysts at the vampire squid expect a free trade deal with the EU and “substantial room” for a strong economic rebound in 2021, as activity remains depressed and the UK is well positioned for vaccine distribution. Both should support GBP and UK domestic stocks, whilst they do not see a move up in sterling on a Brexit breakthrough as a significant barrier to FTSE 100 performance. Back to the strong pound = strong UK equities correlation of old. Meanwhile, the FTSE 100 has an expected 2021 dividend yield of 4 per cent, making it the most attractive among developed market stock indices. 

Read what our resident economic Chris Dillow thinks on the 'value cycle'

To continue reading...
REGISTER FOR FREE TODAY
  • Read 3 articles for free each month
  • Educational articles and topical investment guides
  • In-depth podcast episodes by our writers and industry professionals
  • Interactive live webinars on investment themes that matter
Have an account? Sign in